Business · 25/03/2013Updated: 10/17/2026 · 1 min read
FDA Clears BENADRYL Injection and Two Other Drug Products for Sale
Summary
The Food and Drug Administration (FDA) has ruled that BENADRYL (diphenhydramine hydrochloride) Injection and two other drug products were not withdrawn from sale due to safety or effectiveness concerns, allowing the FDA to continue approving abbreviated new drug applications (ANDAs) for these products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →